BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 6, 2006
View Archived Issues
Stem cell transfer reduces infarct size in ST-segment elevation myocardial infarction
Read More
T cells armed with bispecific antibodies investigated in cancer
Read More
Schering-Plough presents Q4 highlights
Read More
Acceptance of trastuzumab-DM1 IND triggers milestone to ImmunoGen
Read More
Grant supports DeveloGen's development of beta-cell regeneration drugs
Read More
Optimization of route and schedule of IC-41 for hepatitis C
Read More
New attenuated ETEC vaccine completes phase I study
Read More
IDM Pharma closes enrollment in phase II EP-2101 therapeutic vaccine trial
Read More
New phase II study investigates PDX-101 for T-cell lymphomas
Read More
The phytochemical beta-cryptoxanthin prevents bone loss in animal model
Read More
BTG licenses amyloid-induced toxicity inhibitors to Senexis
Read More
Nuvigil NDA action date extended by three months
Read More
ARQ-197 begins phase I study in cancer patients
Read More
Apoxis receives orphan drug designation for APO-200
Read More
Nabi updates progress with Civacir
Read More
CS-917 studied in phase IIb trial for type 2 diabetes
Read More
Phase I study for AB-1001 transdermal patch in CINV
Read More
Fast track designation for rifalazil in peripheral arterial disease
Read More
First phase III trial for EUR-1008M in patients with pancreatic insufficiency
Read More
Teva announces final results of merger consideration for Ivax acquisition
Read More
Compassionate use IND approved for Davanat/5-FU in cholangiocarcinoma
Read More
New trial investigates Ad2/HIF-1alpha/VP16 for intermittent claudication
Read More
Nicotine addiction vaccine surpasses target antibody level in dose-optimization study
Read More
Efficacy shown for ISTA's tobramycin / prednisolone acetate combination product
Read More
Intravenous Keppra receives European positive opinion, FDA approvable letter
Read More
Macugen approved in Europe for wet AMD
Read More
Approval for new formulation of Imitrex Injection
Read More
New treatments for cancer covered in recent patents
Read More
Recently reported novel agents for obesity and lipoprotein disorders
Read More
